Naphazoline HCl Rx
Generic Name and Formulations:
Naphazoline HCl 1mg (0.1%); oph soln; contains benzalkonium chloride.
Indications for Naphazoline HCl:
For use as a topical ocular vasoconstrictor.
Adults and Children:
Instill 1 or 2 drops in the conjunctival sac(s) every 3–4hrs as needed.
Anatomically narrow angle or in narrow-angle glaucoma.
Hypertension. Cardiovascular abnormalities. Diabetes. Hyperthyroidism. Infection. Injury. Children (esp. infants): may result in CNS depression leading to coma and marked reduction in body temperature. Discontinue if no relief obtained within 48hrs of therapy, if irritation, blurring or redness persists or increases, or if symptoms of systemic absorption occur. Pregnancy (Cat.C). Nursing mothers.
Sympathomimetic (imidazoline derivative).
Concomitant maprotiline or tricyclic antidepressants may potentiate pressor effect. Severe hypertensive crisis possible with concomitant MAOIs.
Ocular (eg, mydriasis, increased redness, irritation, discomfort, blurring, punctate keratitis, lacrimation, increased intraocular pressure); systemic (eg, dizziness, headache, nausea, sweating, nervousness, drowsiness, weakness, hypertension, cardiac irregularities, hyperglycemia).
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL